Alpha-1 antitrypsin deficiency: current therapy and emerging targets.
Expert review of respiratory medicine(2023)
Abstract
With a relatively small population able to participate in clinical studies, increased awareness and diagnosis of AATD is urgently needed. Better, more sensitive clinical parameters will assist in the generation of acceptable and robust evidence of therapeutic effect for current and emerging treatments.
MoreTranslated text
Key words
Alpha1 antitrypsin deficiency,COPD,cirrhosis,emphysema,gene editing,gene therapy,panniculitis,protein folding,siRNA
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined